• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
FDA launches new priority review voucher program for select biopharmas

nanoparticles

An artists impression of influenza molecules The molecules are blue and have multicolored centers
Research

Tiba wins BARDA contract to develop RNAi flu therapeutics

The $749,999 contract will see Tiba Biotech build on previous work to develop new a RNAi-based therapeutic against the H1N1 strain of the swine flu.
Helen Floersh Jul 11, 2024 3:35pm
Digital rendering of a galaxy

Genentech spends $15M to rocket into GenEdit’s NanoGalaxy

Jan 23, 2024 7:00am
An artists concept of a nanoparticle shown in gold against a background with bright shades of purple and pink

Young livers may filter out nanodrugs, stifling their efficacy

Sep 25, 2023 5:30am
Graphic of employees walking out depicting layoffs

NexImmune halves team as cash forces focus on core capabilities

Sep 1, 2023 6:39am
Rainbow colored molecules of DNA

Takeda, Poseida see promising data for hemophilia A gene therapy

Dec 14, 2022 3:15pm
Concept of SARS-CoV-2 or COVID-19

Scientists explore 'mosaic', inhaled COVID-19 vaccine options

Jul 7, 2022 2:34pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings